The endocrine therapy drugs (ETDs) market consists of drugs that are used in the treatment of hormone receptor positive breast cancers and prostate cancers. ETDs work by blocking the effects of estrogen or androgen hormones on cancer cell growth. Some key classes of ETDs include selective estrogen receptor modulators (SERMs), aromatase inhibitors (AIs), estrogen receptor antagonists, and...
Paragraph: Endocrine therapy drugs are used mainly for the treatment of hormone receptor-positive breast cancer. Some common endocrine therapy drugs include selective estrogen receptor modulators (SERMs), aromatase inhibitors, and LHRH agonists. SERMs work by blocking the effects of estrogen in breast tissue, while aromatase inhibitors inhibit the production of estrogens. LHRH agonists, on the...
Endocrine Therapy Drugs (ETDs) are prescribed medications used as a part of cancer treatment to block the effect of estrogen or progesterone on cancer cells. They work by preventing hormones from fueling the growth of hormone-receptor-positive cancers like breast, prostate and ovarian cancer. The global Endocrine Therapy Drugs (ETDs) Market is estimated to be valued at US$ 30434.86 Mn in 2023...